Loading clinical trials...
Loading clinical trials...
This study is being conducted to assess impact of maternal immunisation against pertussis in infants ≤12 months of age before and after introduction of pertussis maternal immunisation in Bogota, Colombia from January 2005-December 2014.
An observational, retrospective, ecological database study which involves systematic screening of the national databases of Bogota, to study pertussis related morbidity and mortality in infants ≤ 12 months of age before and after introduction of pertussis maternal immunisation in Bogota, Colombia from January 2005-December 2014.
Age
0 - 1 years
Sex
ALL
Healthy Volunteers
No
GSK Investigational Site
Bogotá, Colombia
Start Date
October 1, 2015
Primary Completion Date
April 14, 2018
Completion Date
April 14, 2018
Last Updated
February 22, 2024
1
ACTUAL participants
Pertussis maternal immunization
OTHER
Lead Sponsor
GlaxoSmithKline
NCT07203755
NCT07112144
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions